Today: 20 May 2026
Valero stock ends higher to start 2026 — OPEC+ meeting and Jan. 29 earnings are next
4 January 2026
1 min read

Valero stock ends higher to start 2026 — OPEC+ meeting and Jan. 29 earnings are next

NEW YORK, January 4, 2026, 03:45 ET — Market closed

  • Valero (VLO) last closed up about 1.5% at $165.31 on Friday, the first trading day of 2026.
  • Oil ended near $61 a barrel as traders weighed oversupply concerns against fresh geopolitical risks.
  • Valero’s next catalyst is its Jan. 29 earnings release and conference call.

Valero Energy Corp (VLO) shares rose about 1.5% on Friday to close at $165.31, after trading between $162.08 and $165.67. U.S. markets are closed on Sunday.

The move sets up a week where crude supply policy and geopolitical headlines could keep energy prices — and refining margins — in play.

For refiners such as Valero, investors track the crack spread — the gap between the cost of crude and the selling price of fuels such as gasoline and diesel — as a shorthand for earnings power.

Valero said it will release fourth-quarter and full-year 2025 results on Jan. 29, before U.S. markets open, and host a conference call at 10 a.m. ET.

On Friday, Valero snapped a two-session losing streak. The stock traded about 11% below its 52-week high of $185.62 reached in November, and volume came in below its 50-day average, MarketWatch data showed.

Other U.S. refiners also finished higher on Friday, with Marathon Petroleum up about 1.6%, Phillips 66 up about 1.2% and HF Sinclair up about 1.7%.

Crude prices ended little changed to start 2026 after oil’s biggest annual loss since 2020, with Brent settling at $60.75 a barrel and U.S. WTI at $57.32, as traders weighed oversupply concerns against flashpoints including Ukraine and Venezuela. “Oil prices are locked in this long-term trading range,” said Phil Flynn, a senior analyst at Price Futures Group. Reuters

OPEC+ is expected to keep output policy steady at a Sunday meeting, sources told Reuters, as the group continues to pause supply increases for the first quarter.

For Valero, the balance matters because shifts in crude supply can change feedstock costs, while moves in wholesale gasoline and diesel prices flow directly into refining margins.

Before the next U.S. stock session, traders will look for any immediate oil-price reaction to the OPEC+ decision and further signals on supply risks tied to sanctions and conflict.

Investors will also keep an eye on U.S. inventory data that can move fuel prices and crack spreads. The Energy Information Administration’s Weekly Petroleum Status Report is typically released at 10:30 a.m. ET on Wednesdays.

Valero’s Jan. 29 report is the next company-specific checkpoint, with investors watching management’s read on refining margins, utilization and the company’s outlook for 2026.

Stock Market Today

No summaries found on the roundup post.

Latest articles

Wall Street Hit by Yield Jolt With Nvidia Up Next

Wall Street Hit by Yield Jolt With Nvidia Up Next

20 May 2026
U.S. stock ETFs remained lower late Tuesday after Wall Street’s main indexes fell for a third straight session, pressured by rising Treasury yields and caution ahead of Nvidia’s earnings. The SPDR S&P 500 ETF dropped 0.7% to $733.73. The 10-year Treasury yield hit 4.687%, its highest since January 2025, before easing. Nvidia shares slipped 0.7% after hours, with traders bracing for a major move post-earnings.
Viavi Stock Drops After $500 Million Share Sale Plan — The Debt Move Investors Can’t Ignore

Viavi Stock Drops After $500 Million Share Sale Plan — The Debt Move Investors Can’t Ignore

20 May 2026
Viavi Solutions shares dropped 7.1% in after-hours trading Tuesday after the company announced a $500 million public stock offering aimed at repaying debt. The offering, unveiled just after the Nasdaq close, could add roughly 10.1 million new shares. Viavi plans to use proceeds to pay down a $450 million loan. Total debt would fall to $650 million, according to a preliminary SEC filing.
Spyre Therapeutics stock slides 6.6% after New Year session; $30 level and 2026 trial data in focus
Previous Story

Spyre Therapeutics stock slides 6.6% after New Year session; $30 level and 2026 trial data in focus

Baidu stock today: BIDU jumps on Kunlunxin Hong Kong IPO plan as AI-chip frenzy builds
Next Story

Baidu stock today: BIDU jumps on Kunlunxin Hong Kong IPO plan as AI-chip frenzy builds

Go toTop